Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro

被引:0
作者
Kilian, O
Flesch, I
Wenisch, S
Taborski, B
Jork, A
Schnettler, R
Jonuleit, T
机构
[1] Univ Giessen, Dept Trauma Surg, D-35392 Giessen, Germany
[2] Univ Tubingen, Dept Trauma Surg, Tubingen, Germany
[3] Cellmed AG, Alzenau, Germany
关键词
platelet growth factor; PDGF; TGF-beta; endothelial cell; mesenchymal cells;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present in vitro study has been to investigate the effects of a enriched platelet derived growth factors on proliferation and migration of human endothelial and mesenchymal stem cells and on osteogenic differentiation of stem cells. Platelet rich plasma has been produced, yielding a four time higher number of thrombocytes than normal plasma. Degranulation of platelets has been performed by means of calcium and thrombin. Plasma has served as a control, whereas plasma in combination with calcium and thrombin was used to distinguish the difference between calcium and/or thrombin mediated effects and growth factor induced effects on the cells. The observed enhanced proliferation and migration of endothelial cells towards the platelet derived growth factors was driven by the plasma component of these preparations. However PDGF solely stimulated the migration and proliferation of mesenchymal stem cells. The increased osteogenic differentiation of growth factor treated mesenchymal stem cells was mostly driven by the high level 4 calcium used for the platelets degranulation. In summery, the different components of platelet derived growth factors work together to influence human endothelial and mesenchymal stem cells. This is of special clinically interest regarding the stimulation of bone healing in orthopaedic and traumatic surgery.
引用
收藏
页码:337 / 344
页数:8
相关论文
共 48 条
  • [11] Carlson E R, 2000, Alpha Omegan, V93, P26
  • [12] Platelet-rich plasma - Clinical applications in dentistry
    Carlson, NE
    Roach, RB
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2002, 133 (10) : 1383 - 1386
  • [13] Cassiede P, 1996, J BONE MINER RES, V11, P1264
  • [14] Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO
  • [15] 2-1
  • [16] PLATELET-DERIVED GROWTH-FACTOR (PDGF) IN PATIENTS WITH DIFFERENT DEGREES OF CHRONIC ARTERIAL OBSTRUCTIVE DISEASE
    CIMMINIELLO, C
    ARPAIA, G
    ALOISIO, M
    UBERTI, T
    ROSSI, F
    POZZI, F
    BONFARDECI, G
    [J]. ANGIOLOGY, 1994, 45 (04) : 289 - 293
  • [17] Mechanism of action of platelet-derived growth factor
    ClaessonWelsh, L
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1996, 28 (04) : 373 - 385
  • [18] Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its α receptor
    De Marchis, F
    Ribatti, D
    Giampietri, C
    Lentini, A
    Faraone, D
    Scoccianti, M
    Capogrossi, MC
    Facchiano, A
    [J]. BLOOD, 2002, 99 (06) : 2045 - 2053
  • [19] DUGRILLON A, 2002, INT J ORAL MAXILLOF, V31, P15
  • [20] PDGF ALPHA-RECEPTORS AND BETA-RECEPTORS ACTIVATE UNIQUE AND COMMON SIGNAL TRANSDUCTION PATHWAYS
    ERIKSSON, A
    SIEGBAHN, A
    WESTERMARK, B
    HELDIN, CH
    CLAESSONWELSH, L
    [J]. EMBO JOURNAL, 1992, 11 (02) : 543 - 550